USDA’s Approval Signals Advancement in Land-Based Production of Essential Fatty Acids
Yield10 Bioscience (YTEN) has achieved a significant regulatory milestone, with the USDA-APHIS’s Biotechnology Regulatory Services (BRS) determining that its genetically engineered Camelina sativa varieties, developed to produce omega-3 fatty acids, are exempt from certain regulations under 7 CFR part 340. This decision paves the way for commercial-scale production of omega-3 oils, addressing the growing demand for these essential nutrients in aquafeed and human nutrition.
The approval is a crucial step for Yield10, as it plans to focus on executing its development program, building seed inventory, and engaging potential commercial partners to facilitate the sale of omega-3 oil and meal in target markets. By utilizing Camelina as a land-based production platform, Yield10 aims to provide a reliable supply of omega-3 fatty acids, reducing dependency on ocean-caught fish as the primary source.
Yield10’s collaboration with Rothamsted and the subsequent partnership with BioMar Group underscores its commitment to revolutionizing the production of omega-3 oils. With continued field testing, seed scale-up activities, and the development of second-generation omega-3 Camelina lines, Yield10 is poised to play a significant role in meeting the global demand for essential fatty acids while ensuring sustainability and regulatory compliance in its operations.
Read original press release:here
You might like this article:Shake Shack Taps Papa John’s CEO Rob Lynch as New Chief
